U.S. Aesthetic Injectable Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Hyaluronic Acid (HA), Botulinum Toxin), By Application (Facial Line Correction, Lip Augmentation), By End-use (Medical Spas, Dermatology Clinics), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Product
                       1.2.2. Application
                       1.2.3. End Use
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Volume price analysis (Model 1)
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Application outlook
                       2.2.3. End use outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Aesthetic Injectable Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Rising demand for minimally invasive procedures
                           3.2.1.2. Expanding acceptance among male and younger demographics
                           3.2.1.3. Continuous product innovation and longer-lasting formulations
                       3.2.2. Market restraint analysis
                           3.2.2.1. Restricted availability and practitioner access in suburban and rural areas
                           3.2.2.2. Regulatory constraints and lack of insurance coverage
                   3.3. U.S. Aesthetic Injectable Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. U.S. Aesthetic Injectable Market: Product Estimates & Trend Analysis
                   4.1. U.S. Aesthetic Injectable Market: Product Dashboard
                   4.2. U.S. Aesthetic Injectable Market: Product Movement Analysis
                   4.3. U.S. Aesthetic Injectable Market by Product, Revenue
                   4.4. Hyaluronic Acid (HA)
                       4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   4.5. Botulinum Toxin (Botox)
                       4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   4.6. Aquatic Light Injections
                       4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   4.7. Others
                       4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Aesthetic Injectable Market: Application Estimates & Trend Analysis
                   5.1. U.S. Aesthetic Injectable Market: Application Dashboard
                   5.2. U.S. Aesthetic Injectable Market: Application Movement Analysis
                   5.3. U.S. Aesthetic Injectable Market by Application, Revenue
                   5.4. Facial Line Correction
                       5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   5.5. Lip Augmentation
                       5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   5.6. Face Lift
                       5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   5.7. Acne Scar Treatment
                       5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   5.8. Lipoatrophy Treatment
                       5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   5.9. Others
                       5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. U.S. Aesthetic Injectable Market: End Use Estimates & Trend Analysis
                   6.1. U.S. Aesthetic Injectable Market: End Use Dashboard
                   6.2. U.S. Aesthetic Injectable Market: End Use Movement Analysis
                   6.3. U.S. Aesthetic Injectable Market by End Use, Revenue
                   6.4. Medical Spas
                       6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   6.5. Dermatology Clinics
                       6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                   6.6. Hospitals
                       6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Manufacturers
                   7.2. Company/Competition Categorization
                       7.2.1. Key company market share analysis, 2024
                   7.3. Company Profiles
                       7.3.1. Ipsen Pharma
                           7.3.1.1. Company overview
                           7.3.1.2. Financial performance
                           7.3.1.3. Product benchmarking
                           7.3.1.4. Strategic initiatives
                       7.3.2. AbbVie, Inc.
                           7.3.2.1. Company overview
                           7.3.2.2. Financial performance
                           7.3.2.3. Product benchmarking
                           7.3.2.4. Strategic initiatives
                       7.3.3. Merz GmbH and Co. KGaA
                           7.3.3.1. Company overview
                           7.3.3.2. Financial performance
                           7.3.3.3. Product benchmarking
                           7.3.3.4. Strategic initiatives
                       7.3.4. Galderma
                           7.3.4.1. Company overview
                           7.3.4.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.4.4. Strategic initiatives
                       7.3.5. Prollenium Medical Technologies, Inc.
                           7.3.5.1. Company overview
                           7.3.5.2. Financial performance
                           7.3.5.3. Product benchmarking
                           7.3.5.4. Strategic initiatives
                       7.3.6. Tiger Aesthetics Medical, LLC
                           7.3.6.1. Company overview
                           7.3.6.2. Financial performance
                           7.3.6.3. Product benchmarking
                           7.3.6.4. Strategic initiatives
                       7.3.7. Sinclair Pharma
                           7.3.7.1. Company overview
                           7.3.7.2. Financial performance
                           7.3.7.3. Product benchmarking
                           7.3.7.4. Strategic initiatives
                       7.3.8. Medytox, Inc.
                           7.3.8.1. Company overview
                           7.3.8.2. Financial performance
                           7.3.8.3. Product benchmarking
                           7.3.8.4. Strategic initiatives
                       7.3.9. Revance Therapeutics, Inc.
                           7.3.9.1. Company overview
                           7.3.9.2. Financial performance
                           7.3.9.3. Product benchmarking
                           7.3.9.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. aesthetic injectable market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. aesthetic injectable market, by application, 2018 - 2030 (USD Million)
Table 4 U.S. aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
Table 5 Participant’s overview
Table 6 Financial performance
Table 7 Key companies undergoing expansions
Table 8 Key companies undergoing acquisitions
Table 9 Key companies undergoing collaborations
Table 10 Key companies launching new services
Table 11 Key companies undergoing partnerships
Table 12 Key companies undertaking other strategies

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 U.S. aesthetic injectable market segmentation
Fig. 7 Market snapshot, 2024
Fig. 8 Market trends & outlook
Fig. 9 Market driver relevance analysis (current & future impact)
Fig. 10 Market restraint relevance analysis (current & future impact)
Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
Fig. 12 Porter’s five forces analysis
Fig. 13 U.S. Aesthetic Injectable Market: Product Outlook Key Takeaways
Fig. 14 U.S. Aesthetic Injectable Market: Product Movement Analysis
Fig. 15 Hyaluronic acid (HA) market, 2018 - 2030 (USD Million)
Fig. 16 Botulinum toxin (Botox) market, 2018 - 2030 (USD Million)
Fig. 17 Aquatic light injections market, 2018 - 2030 (USD Million)
Fig. 18 Others market, 2018 - 2030 (USD Million)
Fig. 19 U.S. aesthetic injectable market: Application outlook key takeaways
Fig. 20 U.S. aesthetic injectable market: Application movement analysis
Fig. 21 Facial line correction market, 2018 - 2030 (USD Million)
Fig. 22 Lip augmentation market, 2018 - 2030 (USD Million)
Fig. 23 Face lift market, 2018 - 2030 (USD Million)
Fig. 24 Acne scar treatment market, 2018 - 2030 (USD Million)
Fig. 25 Lipoatrophy treatment market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 U.S. aesthetic injectable market: End use outlook key takeaways
Fig. 28 U.S. aesthetic injectable market: End use movement analysis
Fig. 29 Medical spas market, 2018 - 2030 (USD Million)
Fig. 30 Dermatology clinics market, 2018 - 2030 (USD Million)
Fig. 31 Hospitals market, 2018 - 2030 (USD Million)
Fig. 32 Strategy framework